Neuromedin B (CAS 87096-84-2)

Neuromedin B is a neuropeptide belonging to the bombesin-like peptide family, notable for its role in regulating physiological processes through its interaction with the Neuromedin B receptor (NMBR), a G-protein-coupled receptor. This receptor is distributed in various tissues, including the brain, gastrointestinal tract, and lungs. The binding of Neuromedin B to NMBR activates a signaling cascade involving the activation of phospholipase C, which subsequently increases intracellular calcium levels. This molecular action triggers diverse physiological responses such as neurotransmitter release, smooth muscle contraction, and hormonal secretion regulation. In research, Neuromedin B is extensively used to study the complex signaling pathways of bombesin-like peptides and their implications in various biological functions and disease states. It serves as a crucial tool for dissecting the mechanisms of neuromodulation and neuroendocrine interactions, contributing significantly to the broader understanding of peptide-mediated signaling in both central and peripheral systems. By investigating these pathways, scientists gain insights into the regulatory networks that influence numerous physiological responses, enhancing our comprehension of cellular communication and potential dysregulations that occur in certain pathologies, all while steering clear of direct clinical or therapeutic applications.